228
Views
0
CrossRef citations to date
0
Altmetric
EXPERT OPINION

Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

ORCID Icon, , & ORCID Icon
Pages 895-900 | Received 18 Jul 2023, Accepted 06 Sep 2023, Published online: 03 Oct 2023

References

  • Smith AD, Refsum H. Homocysteine - from disease biomarker to disease prevention. J Intern Med. 2021;290(4):826–854. doi:10.1111/joim.13279.
  • Elias MF. Reclaiming the importance of homocysteine as a marker of cardiovascular and neurologic disease. J Intern Med. 2021;290(5):1098–1099. doi:10.1111/joim.13305.
  • Spence JD, Yi Q, Hankey GJ. B vitamins in stroke prevention: time to reconsider. Lancet Neurol. 2017;16(9):750–760. doi:10.1016/S1474-4422(17)30180-1
  • Spence JD, Hankey GJ. Problem in the recent American heart association guideline on secondary stroke prevention: b vitamins to lower homocysteine do prevent stroke. Stroke. 2022;53(8):2702–2708. doi:10.1161/STROKEAHA.122.038640
  • Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association/American stroke association. Stroke. 2021;52(7):e364–e467. doi:10.1161/STR.0000000000000375
  • Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT Randomized Clinical Trial. JAMA. 2015;313(13):1325–1335. doi:10.1001/jama.2015.2274
  • Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8(8):CD006612. doi:10.1002/14651858.CD006612.pub5
  • Elias MF, Brown CJ. Medical foods for lowering homocysteine in hypertensive patients. J Clin Hypertens. 2023;25(1):111–114. doi:10.1111/jch.14608
  • House AA, Eliasson M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010;303(16):1603–1609. doi:10.1001/jama.2010.490
  • Willems FF, Boers GH, Blom HJ, Aengevaeren WR, Verheugt FW. Pharmacokinetic study on the utilization of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol. 2004;141(5):825–830. doi:10.1038/sj.bjp.0705446
  • Stover PJ, Durga J, Field MS. Folate nutrition and blood-brain barrier dysfunction. Curr Opin Biotechnol. 2017;44:146–152. doi:10.1016/j.copbio.2017.01.006
  • Smith DE, Hornstra JM, Kok RM, Blom HJ, Smulders YM. Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism. Clin Chem Lab Med. 2013;51(8):1643–1650. doi:10.1515/cclm-2012-0694
  • Liang Y, Liu B, Xiao Y, et al. Retinal neurovascular changes in patients with ischemic stroke investigated by optical coherence tomography angiography. Front Aging Neurosci. 2022;14:834560. doi:10.3389/fnagi.2022.834560
  • Liu Z, Jiang H, Townsend JH, Wang J. Improved Retinal Microcirculation in Mild Diabetic Retinopathy Patients Carrying MTHFR Polymorphisms Who Received the Medical Food, Ocufolin®. Clin Ophthalmol. 2022;16:1497–1504.
  • Liu Z, Jiang H, Townsend JH, Wang J. Effects of Ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene. BMJ Open Diabetes Res Care. 2021;9(1):e002327. doi:10.1136/bmjdrc-2021-002327
  • Schmidl D, Howorka K, Szegedi S, et al. A pilot study to assess the effect of a three-month vitamin supplementation containing l-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes. Mol Vis. 2020;26:326–333.